The efficacy of crizotinib in patients with -positive nonsmall cell lung cancer
Molecular profiling of nonsmall cell lung cancer (NSCLC) contributes to better understanding the different molecular subtypes of this heterogeneous group of diseases. The discovery of oncogenic ALK rearrangements in NSCLC and the subsequent success in their therapeutic targeting with crizotinib rein...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publishing
2015-06-01
|
| Colección: | Therapeutic Advances in Respiratory Disease |
| Acceso en línea: | https://doi.org/10.1177/1753465815577738 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|